Sign In
Buy NMR
$9.68
+0.120 (+1.26%)
At Close: Jul 31, 2026
Analysts Conflicted on These Conglomerates Names: Masco (MAS), Avantor (AVTR) and O-I Glass (OI)
02:41pm, Thursday, 30'th Apr 2020
Analysts have been eager to weigh in on the Conglomerates sector with new ratings on Masco (MAS), Avantor (AVTR) and O-I Glass (OI). Masco (MAS) In a
Analysts Offer Insights on Technology Companies: Maxim Integrated (MXIM), nVent Electric (NVT) and Criteo SA (CRTO)
02:41pm, Thursday, 30'th Apr 2020
Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Maxim Integrated (MXIM), nVent Electric (NVT) and Criteo
Companies in the
Technology sector have received a lot of coverage today as analysts
weigh in on Maxim Integrated (
MXIM
–
Research Report
), nVent Electric (
NVT
–
Research Report
) and Criteo SA
Nomura Believes Yum China Holdings (YUMC) Still Has Room to Grow
02:40pm, Thursday, 30'th Apr 2020
Nomura analyst Sandy Shao maintained a Buy rating on Yum China Holdings (YUMC) yesterday and set a price target of $56.50. The company's shares closed
Nomura Keeps a Hold Rating on Akamai (AKAM)
02:39pm, Thursday, 30'th Apr 2020
In a report released yesterday, Gregory McNiff from Nomura maintained a Hold rating on Akamai (AKAM), with a price target of $115.00. The company's shares
Sarepta Therapeutics (SRPT) Gets a Buy Rating from Nomura
02:39pm, Thursday, 30'th Apr 2020
In a report released yesterday, Christopher Marai from Nomura maintained a Buy rating on Sarepta Therapeutics (SRPT), with a price target of $230.00. The
Nomura Sticks to Its Buy Rating for Mastercard (MA)
02:39pm, Thursday, 30'th Apr 2020
Nomura analyst Bill Carcache maintained a Buy rating on Mastercard (MA) yesterday and set a price target of $334.00. The company's shares closed last
Nomura Believes Syndax Pharmaceuticals (SNDX) Won't Stop Here
02:37pm, Thursday, 30'th Apr 2020
In a report issued on April 28, Christopher Marai from Nomura maintained a Buy rating on Syndax Pharmaceuticals (SNDX), with a price target of $16.00. The
Nomura Believes Syndax Pharmaceuticals (NASDAQ: SNDX) Won’t Stop Here
02:37pm, Thursday, 30'th Apr 2020
In a report issued on April 28,
Christopher Marai
from Nomura maintained a
Buy
rating on Syndax Pharmaceuticals (
SNDX
–
Research Report
), with a price target of
$16.00
. The company’s shares clo
VICI Properties (VICI) Gets a Buy Rating from Nomura
02:30pm, Thursday, 30'th Apr 2020
Nomura analyst Daniel Adam maintained a Buy rating on VICI Properties (VICI) on April 27 and set a price target of $23.00. The company's shares closed
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Universal Health (UHS), Deciphera Pharmaceuticals (DCPH)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Universal Health (
UHS
–
Research Report
), Deciphera Pharmaceuticals (
DCPH
–
Research Report
) an
Analysts' Opinions Are Mixed on These Services Stocks: Martin Midstream (MMLP), TAL Education Group (TAL) and National-Oilwell (NOV)
02:29pm, Thursday, 30'th Apr 2020
Analysts have been eager to weigh in on the Services sector with new ratings on Martin Midstream (MMLP), TAL Education Group (TAL) and National-Oilwell
Analysts have been eager to weigh in on the Services sector with new ratings on Martin Midstream (MMLP – Research
Analysts' Opinions Are Mixed on These Financial Stocks: Gaming and Leisure (GLPI), Synovus (SNV) and Brown & Brown (BRO)
02:28pm, Thursday, 30'th Apr 2020
Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Gaming and Leisure (GLPI), Synovus (SNV) and Brown &
